You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 155 No. 6, 27 MARCH 1995 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Review Articles
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Treatment of Hypertension in Women

Norman M. Kaplan, MD

Arch Intern Med. 1995;155(6):563-567.


Abstract



More women than men eventually develop hypertension, but they suffer less cardiovascular damage as a consequence. Primary hypertension in women has a greater volume component, often related to commonly associated obesity. Most lifestyle modifications have more to offer women, but women respond in a similar manner to various antihypertensive drugs. However, women appear to receive less benefit from antihypertensive therapy, as measured by morbidity and mortality data in multiple large clinical trials. Women who take oral contraceptives typically have a small rise in blood pressure, and in a small percentage, the rise is sufficient to induce hypertension. The prevalence is likely lower with currently used low-dose estrogen formulations. The use of estrogen for postmenopausal replacement therapy almost never raises the blood pressure, so that concerns about hypertension should not interfere with the use of this valuable therapy.

(Arch Intern Med. 1995;155:563-567)



Author Affiliations



From the Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sex-specific QTLs and interacting loci underlie salt-sensitive hypertension and target organ complications in Dahl S/jrHS hypertensive rats
Herrera et al.
Physiol. Genomics 2006;26:172-179.
ABSTRACT | FULL TEXT  

Hypertension, Menopause, and Coronary Artery Disease Risk in the Women's Ischemia Syndrome Evaluation (WISE) Study
Gierach et al.
J Am Coll Cardiol 2006;47:S50-S58.
ABSTRACT | FULL TEXT  

Renal Characteristics and Effect of Angiotensin Suppression in Oral Contraceptive Users
Ribstein et al.
Hypertension 1999;33:90-95.
ABSTRACT | FULL TEXT  

Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS
Brosnihan et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 1997;273:R1908-R1915.
ABSTRACT | FULL TEXT  

Women and coronary heart disease
DTB 1996;34:28-30.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.